» Articles » PMID: 28482840

Blood and Sputum Eosinophils in COPD; Relationship with Bacterial Load

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2017 May 10
PMID 28482840
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sputum and blood eosinophil counts predict corticosteroid effects in COPD patients. Bacterial infection causes increased airway neutrophilic inflammation. The relationship of eosinophil counts with airway bacterial load in COPD patients is uncertain. We tested the hypothesis that bacterial load and eosinophil counts are inversely related.

Methods: COPD patients were seen at stable state and exacerbation onset. Sputum was processed for quantitative polymerase chain reaction detection of the potentially pathogenic microorganisms (PPM) H. influenzae, M. catarrhalis and S. pneumoniae. PPM positive was defined as total load ≥1 × 10copies/ml. Sputum and whole blood were analysed for differential cell counts.

Results: At baseline, bacterial counts were not related to blood eosinophils, but sputum eosinophil % was significantly lower in patients with PPM positive compared to PPM negative samples (medians: 0.5% vs. 1.25% respectively, p = 0.01). Patients with PPM positive samples during an exacerbation had significantly lower blood eosinophil counts at exacerbation compared to baseline (medians: 0.17 × 10/L vs. 0.23 × 10/L respectively, p = 0.008), while no blood eosinophil change was observed with PPM negative samples.

Conclusions: These findings indicate an inverse relationship between bacterial infection and eosinophil counts. Bacterial infection may influence corticosteroid responsiveness by altering the profile of neutrophilic and eosinophilic inflammation.

Citing Articles

Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP).

Cui X, Xie B, Zhu K, Liao Q, Zhou J, Du S Sci Rep. 2024; 14(1):30406.

PMID: 39638829 PMC: 11621349. DOI: 10.1038/s41598-024-80727-1.


Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.

Baraldo S, Bonato M, Cassia S, Casolari P, De Ferrari L, Tine M Respir Res. 2024; 25(1):315.

PMID: 39160551 PMC: 11334339. DOI: 10.1186/s12931-024-02952-6.


Sputum microbe community alterations induced by long-term inhaled corticosteroid use are associated with airway function in chronic obstructive pulmonary disease patients based on metagenomic next-generation sequencing (mNGS).

Yue Y, Zhang B, He Z, Zheng Y, Wang X, Zhang Q Front Pharmacol. 2024; 15:1323613.

PMID: 38915461 PMC: 11194361. DOI: 10.3389/fphar.2024.1323613.


High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPD.

Perotin J, Muggeo A, Lecomte-Thenot Q, Brisebarre A, Dury S, Launois C Int J Chron Obstruct Pulmon Dis. 2024; 19:765-771.

PMID: 38524398 PMC: 10959750. DOI: 10.2147/COPD.S453526.


Blood Eosinophil Count and Its Determinants in a Chinese Population-Based Cohort.

Yang M, Lv Y, Tang S, Xu D, Li D, Liao Z Respiration. 2024; 103(2):70-78.

PMID: 38253034 PMC: 10871690. DOI: 10.1159/000535989.


References
1.
Wang M, Gao P, Wu X, Chen Y, Feng Y, Yang Q . Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res. 2016; 17(1):153. PMC: 5112750. DOI: 10.1186/s12931-016-0462-0. View

2.
Singh R, Mackay A, Patel A, Garcha D, Kowlessar B, Brill S . Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease. Respir Res. 2014; 15:114. PMC: 4173051. DOI: 10.1186/s12931-014-0114-1. View

3.
Pavord I, Lettis S, Locantore N, Pascoe S, Jones P, Wedzicha J . Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax. 2015; 71(2):118-25. PMC: 4752631. DOI: 10.1136/thoraxjnl-2015-207021. View

4.
Brightling C, Monteiro W, WARD R, Parker D, Morgan M, Wardlaw A . Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000; 356(9240):1480-5. DOI: 10.1016/S0140-6736(00)02872-5. View

5.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View